Cargando…

Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinoma

BACKGROUND: Signet ring cell carcinoma (SRCC) is a rare subtype of colorectal cancer (CRC). The aim of this study was to characterise the genomic alterations and outcomes of SRCC. METHODS: Medical records of metastatic CRC (mCRC) patients whose tumours were evaluated by NGS analysis were reviewed. S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Korphaisarn, Krittiya, Morris, Van, Davis, Jenifer S., Overman, Michael J., Fogelman, David R., Kee, Bryan K., Dasari, Arvind, Raghav, Kanwal P. S., Shureiqi, Imad, Trupti, Metha, Wolff, Robert A., Eng, Cathy, Menter, David G., Hamilton, Stanley, Kopetz, Scott
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738104/ https://www.ncbi.nlm.nih.gov/pubmed/31406299 http://dx.doi.org/10.1038/s41416-019-0548-9

Ejemplares similares

FBXW7 missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinoma
por: Korphaisarn, Krittiya, et al.
Publicado: (2017)

Clinical utility of circulating cell-free DNA in advanced colorectal cancer
por: Pereira, Allan A. Lima, et al.
Publicado: (2017)

Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer
por: Sarshekeh, Amir Mehrvarz, et al.
Publicado: (2017)

Early-Onset Signet-Ring Cell Adenocarcinoma of the Colon: A Case Report and Review of the Literature
por: Khan, Maliha, et al.
Publicado: (2017)

Association of Prediagnosis Obesity and Postdiagnosis Aspirin With Survival From Stage IV Colorectal Cancer
por: Davis, Jennifer S., et al.
Publicado: (2022)

MET amplification in metastatic colorectal cancer: an acquired response to EGFR inhibition, not a de novo phenomenon
por: Raghav, Kanwal, et al.
Publicado: (2016)

Overall Survival in Phase 3 Clinical Trials and the Surveillance, Epidemiology, and End Results Database in Patients With Metastatic Colorectal Cancer, 1986-2016: A Systematic Review
por: Shen, Chan, et al.
Publicado: (2022)

Antibiotic Exposure Does Not Impact Immune Checkpoint Blockade Response in MSI-H/dMMR Metastatic Colorectal Cancer: A Single-Center Experience
por: Serpas Higbie, Victoria, et al.
Publicado: (2022)

Mechanisms of resistance to EGFR-targeted therapies in colorectal cancer: more than just genetics
por: Parseghian, Christine, et al.
Publicado: (2023)

Phase II study of durvalumab (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC)
por: Johnson, Benny, et al.
Publicado: (2022)

Survival improvement for patients with metastatic colorectal cancer over twenty years
por: Zeineddine, Fadl A., et al.
Publicado: (2023)

Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer
por: Chen, Z-Y, et al.
Publicado: (2015)

Retrospective analysis of systemic chemotherapy and total parenteral nutrition for the treatment of malignant small bowel obstruction
por: Chouhan, Jay, et al.
Publicado: (2015)

Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer
por: Advani, Shailesh Mahesh, et al.
Publicado: (2019)

Cost–Utility and Budget Impact Analyses of Oral Chemotherapy for Stage III Colorectal Cancer: Real-World Evidence after Policy Implementation in Thailand
por: Phisalprapa, Pochamana, et al.
Publicado: (2023)

The Association of Alternate VEGF Ligands with Resistance to Anti-VEGF Therapy in Metastatic Colorectal Cancer
por: Lieu, Christopher H., et al.
Publicado: (2013)

Phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory CIMP-high metastatic colorectal cancer: evaluation of circulating methylated vimentin
por: Overman, Michael J., et al.
Publicado: (2016)

Underreporting of race/ethnicity in COVID-19 research
por: Raghav, Kanwal, et al.
Publicado: (2021)

Bintrafusp Alfa, an Anti-PD-L1:TGFβ Trap Fusion Protein, in Patients with ctDNA-positive, Liver-limited Metastatic Colorectal Cancer
por: Morris, Van K., et al.
Publicado: (2022)

Association between Pathological Complete Response and Outcome Following Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients
por: Luangdilok, Sutima, et al.
Publicado: (2014)

Effect of Primary Tumor Location on Second- or Later-Line Treatment With Anti-Epidermal Growth Factor Receptor Antibodies in Patients With Metastatic Colorectal Cancer: A Retrospective Multi-Center Study
por: Archwamety, Anita, et al.
Publicado: (2022)

Early Images of Colorectal Signet Ring Cell Carcinoma
por: Fujita, Kinya, et al.
Publicado: (2022)

Integrated clinico-molecular profiling of appendiceal adenocarcinoma reveals a unique grade-driven entity distinct from colorectal cancer
por: Raghav, Kanwal, et al.
Publicado: (2020)

Autologous humanized mouse models to study combination and single-agent immunotherapy for colorectal cancer patient-derived xenografts
por: Kanikarla Marie, Preeti, et al.
Publicado: (2022)

BRAF mutation in colorectal carcinomas with signet ring cell component
por: Yalcin, Serap, et al.
Publicado: (2017)

Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer
por: Varkaris, Andreas, et al.
Publicado: (2019)

Characteristics and prognostic factors of colorectal mucinous adenocarcinoma with signet ring cells
por: Kong, Xiangquan, et al.
Publicado: (2017)

Clinicopathologic and Molecular Features of Colorectal Adenocarcinoma with Signet-Ring Cell Component
por: Wei, Qing, et al.
Publicado: (2016)

The prognostic significance of different proportion of signet-ring cells of colorectal carcinoma
por: Chen, Wei, et al.
Publicado: (2022)

Colorectal Signet Ring Cell Carcinoma Presenting as Ulcerating Rectosigmoid Stricture
por: Chen, Bing, et al.
Publicado: (2023)

Platelet Metabolism and Other Targeted Drugs; Potential Impact on Immunotherapy
por: Kanikarla-Marie, Preeti, et al.
Publicado: (2018)

Primary pulmonary lymphoepithelioma‐like carcinoma treated with immunotherapy: A case report and literature review
por: Archwamety, Anita, et al.
Publicado: (2022)

Signet Ring Cell Colorectal and Appendiceal Cancer: A Small Signet Ring Cell Component Is Also Associated with Poor Outcome
por: Enblad, Malin, et al.
Publicado: (2023)

Clinical Features and Prognosis of Resectable Primary Colorectal Signet-Ring Cell Carcinoma
por: Lee, Ho-Su, et al.
Publicado: (2015)

Signet ring colorectal carcinoma: Do we need to improve the treatment algorithm?
por: Tamhankar, Anup Sunil, et al.
Publicado: (2016)

Clinical Significance of Signet-Ring-Cell Colorectal Cancer as a Prognostic Factor
por: Yun, Sang-Oh, et al.
Publicado: (2017)

Clinicopathological and Molecular Characteristics of Colorectal Signet Ring Cell Carcinoma: A Review
por: An, Yang, et al.
Publicado: (2021)

Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical Companies
por: Unger, Joseph M, et al.
Publicado: (2020)

Retrospective study of nonmucinous appendiceal adenocarcinomas: role of systemic chemotherapy and cytoreductive surgery
por: Uemura, Marc, et al.
Publicado: (2017)

The Provocative Roles of Platelets in Liver Disease and Cancer
por: Kanikarla Marie, Preeti, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ppkp5b6fv86qs7hdn7j2116ad4